About Dermatitis.ai

Our Mission

Dermatitis.ai exists because most skin health information online is either too superficial to be useful, too technical to be accessible, or compromised by undisclosed commercial interests. We believe people managing eczema and dermatitis deserve better.

Our goal is to provide the kind of information a board-certified dermatologist would share with a patient in a 30-minute appointment: accurate, practical, honest about what we know and what we don’t, and free of the marketing spin that dominates health content online.

Dermatitis.ai is part of the BuiltForAI Healthcare network, a collection of condition-specific health information sites built with the same editorial standards and commitment to clinical accuracy.

Editorial Standards

Every piece of content on Dermatitis.ai is held to the following standards:

Evidence-based. All medical claims are supported by peer-reviewed research, clinical guidelines, or established dermatological practice. We cite specific studies and guidelines, not vague appeals to authority.
Clinically reviewed. Content is reviewed by the BuiltForAI Healthcare editorial team with input from board-certified dermatologists. We do not publish content that has not been reviewed for medical accuracy.
Transparent about uncertainty. Where evidence is mixed, emerging, or limited, we say so. We do not present preliminary findings as established fact.
Free of commercial influence. Our content is not sponsored by pharmaceutical companies, device manufacturers, or skincare brands. When we mention specific products or medications, it is because they are clinically relevant, not because someone paid us to include them.
Written for real people. We explain medical concepts in plain language without dumbing them down. Technical terms are used when they add precision and are always defined in context.
Regularly updated. Medical knowledge evolves. We review and update content as new treatments are approved, guidelines change, or new evidence emerges. Every page shows when it was last reviewed.

Medical Review Process

Our content development follows a structured process designed to ensure accuracy and clinical relevance:

Research. Content begins with a review of current clinical guidelines (AAD, NICE, EADV), recent systematic reviews, and landmark clinical trials relevant to the topic.
Drafting. Articles are written with attention to clinical accuracy, avoiding common medical myths and over-simplifications that can mislead patients.
Clinical review. Content is reviewed by the BuiltForAI Healthcare editorial board for medical accuracy, appropriate nuance, and potential for patient harm.
Revision. Feedback is incorporated. Claims that cannot be adequately supported are removed or qualified.
Publication and monitoring. Published content is monitored for accuracy as new evidence emerges. Major guideline changes trigger immediate review.

Sources We Reference

Our content draws from the following trusted sources in dermatology and skin health:

American Academy of Dermatology (AAD)

Clinical guidelines for atopic dermatitis, contact dermatitis, and other dermatologic conditions.

National Eczema Association (NEA)

Patient-focused research updates, clinical trial information, and eczema management resources.

Journal of the American Academy of Dermatology (JAAD)

Peer-reviewed research on dermatitis pathophysiology, treatment efficacy, and clinical outcomes.

UpToDate

Evidence-based clinical decision support used by dermatologists and primary care physicians worldwide.

British Journal of Dermatology

International peer-reviewed research on skin diseases, including major biologic and JAK inhibitor trials.

European Academy of Dermatology (EADV)

European treatment guidelines and consensus statements on atopic dermatitis management.

FDA Drug Approvals

Official approval data, prescribing information, and safety communications for dermatologic medications.

Cochrane Reviews

Systematic reviews and meta-analyses of treatment interventions for eczema and dermatitis.

About BuiltForAI, LLC

Dermatitis.ai is developed and maintained by BuiltForAI, LLC, an AI development and digital health company building a network of condition-specific health information sites.

The BuiltForAI Healthcare network includes sites covering joint pain, knee replacement, hip replacement, acid reflux, in-home care, dermatitis, bronchitis, and more. Each site follows the same editorial standards and is built with the same commitment to clinical accuracy and patient trust.

We believe the future of health information is AI-assisted, evidence-based, and patient-centered. Our sites combine curated expert content with AI-powered tools (like our Derm Dr. AI chat assistant and eczema severity assessment) to help people understand their conditions and make informed decisions about their care.